このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Alibaba Health Information Technology 将来の成長

Future 基準チェック /46

Alibaba Health Information Technology利益と収益がそれぞれ年間23.9%と10.8%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に13.7% 23.5%なると予測されています。

主要情報

24.0%

収益成長率

23.5%

EPS成長率

Consumer Retailing 収益成長	28.1%
収益成長率	10.6%
将来の株主資本利益率	13.8%
アナリストカバレッジ	Good
最終更新日	25 Sep 2024

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

SHSC:241 - アナリストの将来予測と過去の財務データ ( )CNY Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
3/31/2027	39,113	2,621	3,094	3,342	13
3/31/2026	34,877	2,087	2,353	2,342	14
3/31/2025	31,407	1,614	1,769	1,804	16
3/31/2024	27,027	883	1,057	1,080	N/A
12/31/2023	27,623	851	851	871	N/A
9/30/2023	28,218	817	644	662	N/A
6/30/2023	27,491	675	447	459	N/A
3/31/2023	26,763	536	250	256	N/A
12/31/2022	24,742	332	284	293	N/A
9/30/2022	22,720	128	318	331	N/A
6/30/2022	21,649	-69	363	378	N/A
3/31/2022	20,578	-266	409	424	N/A
12/31/2021	19,146	-216	714	733	N/A
9/30/2021	17,714	-167	1,018	1,041	N/A
6/30/2021	16,616	91	1,005	1,025	N/A
3/31/2021	15,518	349	992	1,009	N/A
12/31/2020	14,080	313	830	842	N/A
9/30/2020	12,642	278	668	674	N/A
6/30/2020	11,119	136	619	629	N/A
3/31/2020	9,596	-7	570	584	N/A
12/31/2019	8,465	-3	564	577	N/A
9/30/2019	7,334	1	558	570	N/A
6/30/2019	6,215	-40	474	483	N/A
3/31/2019	5,096	-82	390	396	N/A
12/31/2018	4,264	-91	367	373	N/A
9/30/2018	3,432	-100	344	349	N/A
6/30/2018	2,937	-104	134	139	N/A
3/31/2018	2,443	-107	-76	-70	N/A
12/31/2017	1,876	-152	N/A	-157	N/A
9/30/2017	1,310	-196	N/A	-244	N/A
6/30/2017	892	-202	N/A	-235	N/A
3/31/2017	475	-208	N/A	-226	N/A
12/31/2016	285	-201	N/A	-186	N/A
9/30/2016	94	-194	N/A	-145	N/A
6/30/2016	76	-193	N/A	-131	N/A
3/31/2016	57	-192	N/A	-117	N/A
12/31/2015	44	-173	N/A	-118	N/A
9/30/2015	32	-154	N/A	-119	N/A
6/30/2015	31	-118	N/A	-87	N/A
3/31/2015	30	-81	N/A	-55	N/A
12/31/2014	31	-60	N/A	-8	N/A
9/30/2014	31	-39	N/A	38	N/A
6/30/2014	27	-36	N/A	20	N/A
3/31/2014	22	-31	N/A	1	N/A
12/31/2013	16	-35	N/A	-26	N/A
9/30/2013	12	-39	N/A	-55	N/A

アナリストによる今後の成長予測

収入対貯蓄率: 241の予測収益成長率 (年間23.9% ) は貯蓄率 ( 2.3% ) を上回っています。

収益対市場: 241の収益 ( 23.9% ) はHong Kong市場 ( 11% ) よりも速いペースで成長すると予測されています。

高成長収益: 241の収益は今後 3 年間で大幅に増加すると予想されています。

収益対市場: 241の収益 ( 10.8% ) Hong Kong市場 ( 7.4% ) よりも速いペースで成長すると予測されています。

高い収益成長: 241の収益 ( 10.8% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: 241の自己資本利益率は、3年後には低くなると予測されています ( 13.7 %)。

Alibaba Health Information Technology 将来の成長

Future 基準チェック /46

主要情報

今後の成長に関する最新情報

Alibaba Health Information Technology Limited Provides Earnings Guidance for the Year Ended March 31, 2023

Alibaba Health Information Technology Limited Provides Consolidated Earnings Guidance for the Six Months Ended September 30, 2022

Recent updates

Investor sentiment improves as stock rises 18%

Full year 2024 earnings released: EPS: CN¥0.063 (vs CN¥0.04 in FY 2023)

Alibaba Health Information Technology Limited, Annual General Meeting, Aug 30, 2024

Executive Chairman of the Board recently sold HK$559k worth of stock

Investor sentiment improves as stock rises 15%

New minor risk - Earnings quality

Full year 2024 earnings released: EPS: CN¥0.063 (vs CN¥0.04 in FY 2023)

Alibaba Health Information Technology Limited to Report Fiscal Year 2024 Results on May 27, 2024

Investor sentiment improves as stock rises 19%

Investor sentiment deteriorates as stock falls 18%

New minor risk - Shareholder dilution

First half 2024 earnings released: EPS: CN¥0.033 (vs CN¥0.012 in 1H 2023)

First half 2024 earnings released: EPS: CN¥0.033 (vs CN¥0.012 in 1H 2023)

Alibaba Health Information Technology Limited Announces Executive Changes

Alibaba Health Information Technology Limited to Report First Half, 2024 Results on Nov 28, 2023

Alibaba Health Information Technology Limited Appoints Xu Haipeng as Non-Executive Director

Less than half of directors are independent

Alibaba Health Information Technology Limited Announces Executive Changes and Committee Changes

Full year 2023 earnings released: EPS: CN¥0.04 (vs CN¥0.02 loss in FY 2022)

Alibaba Health Information Technology Limited, Annual General Meeting, Aug 11, 2023

Chairman of the Board & CEO recently sold HK$587k worth of stock

Less than half of directors are independent

Full year 2023 earnings released: EPS: CN¥0.04 (vs CN¥0.02 loss in FY 2022)

Alibaba Health Information Technology Limited Announces Board Changes

Alibaba Health Information Technology Limited to Report Fiscal Year 2023 Final Results on May 23, 2023

Alibaba Health Information Technology Limited Provides Earnings Guidance for the Year Ended March 31, 2023

First half 2023 earnings released: EPS: CN¥0.012 (vs CN¥0.017 loss in 1H 2022)

Alibaba Health Information Technology Limited to Report Q2, 2023 Results on Nov 28, 2022

Less than half of directors are independent

Alibaba Health Information Technology Limited Provides Consolidated Earnings Guidance for the Six Months Ended September 30, 2022

Now 21% undervalued

Now 20% undervalued

Full year 2022 earnings released: CN¥0.02 loss per share (vs CN¥0.026 profit in FY 2021)

Alibaba Health Information Technology Limited, Annual General Meeting, Aug 05, 2022

Alibaba Health Information Technology Limited Announces Executive Changes

Now 21% undervalued

Full year 2022 earnings released: CN¥0.02 loss per share (vs CN¥0.026 profit in FY 2021)

Alibaba Health Information Technology Limited to Report Fiscal Year 2022 Final Results on May 25, 2022

Less than half of directors are independent

Less than half of directors are independent

COO & Executive Director recently bought HK$4.5m worth of stock

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Chairman of the Board & CEO recently bought HK$3.4m worth of stock

Full year 2021 earnings released: EPS CN¥0.026 (vs CN¥0.001 loss in FY 2020)

CFO & Executive Director recently bought HK$284k worth of stock

CFO & Executive Director recently bought HK$284k worth of stock

Full year 2021 earnings released: EPS CN¥0.026 (vs CN¥0.001 loss in FY 2020)

CFO & Executive Director recently sold HK$906k worth of stock

New 90-day high: HK$28.90

New 90-day high: HK$27.45

New 90-day high: HK$23.20

New 90-day high: HK$23.00

Alibaba Health Information Technology Limited to Report First Half, 2021 Results on Nov 25, 2020

Non-Executive Director recently sold HK$6.9m worth of stock

New 90-day low - HK$17.40

Alibaba Health Information Technology Limited has completed a Follow-on Equity Offering in the amount of HKD 10 billion.

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘